logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Vaccine Analysis Strategies Principles And Control 1st Edition Brian K Nunnally

  • SKU: BELL-4970492
Vaccine Analysis Strategies Principles And Control 1st Edition Brian K Nunnally
$ 31.00 $ 45.00 (-31%)

4.8

54 reviews

Vaccine Analysis Strategies Principles And Control 1st Edition Brian K Nunnally instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 14.67 MB
Pages: 665
Author: Brian K. Nunnally, Vincent E. Turula, Robert D. Sitrin (eds.)
ISBN: 9783662450239, 3662450232
Language: English
Year: 2015
Edition: 1

Product desciption

Vaccine Analysis Strategies Principles And Control 1st Edition Brian K Nunnally by Brian K. Nunnally, Vincent E. Turula, Robert D. Sitrin (eds.) 9783662450239, 3662450232 instant download after payment.

This book is an indispensable tool for anyone involved in the research, development, or manufacture of new or existing vaccines. It describes a wide array of analytical and quality control technologies for the diverse vaccine modalities.

Topics covered include the application of both classical and modern bio-analytical tools; procedures to assure safety and control of cross contamination; consistent biological transition of vaccines from the research laboratory to manufacturing scale; whole infectious attenuated organisms, such as live-attenuated and inactivated whole-cell bacterial vaccines and antiviral vaccines using attenuated or inactivated viruses; principles of viral inactivation and the application of these principles to vaccine development; recombinant DNA approaches to produce modern prophylactic vaccines; bacterial subunit, polysaccharide and glycoconjugate vaccines; combination vaccines that contain multiple antigens as well as regulatory requirements and the hurdles of licensure.

Related Products